Cardica has received European Conformite Europeenne (CE) Mark approval for the C-Port Flex A Anastomosis system, which the Redwood, Calif.-based company says is a variation of its C-Port xA Distal Anastomosis System product line.

According to Cardica, the system facilitates the automated anastomosis, or attachment of blood vessels and grafts, during less invasive coronary artery bypass graft procedures.

The U.S. FDA granted the Flex A 510(k) clearance in March.